High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound ...

The Egyptian Drug Authority (EDA) has concluded its participation in activities of CPHI Milan, the premier international ...

The winners of this year’s awards showcase achievements in pharma excellence. CPHI announced the winners of the 2024 Pharma Awards on Oct. 8, 2024 at CPHI Milan in Milan, Italy (1). And the winners ...

Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at Abzena during CPHI Milan. Camper discussed the advancements in conjugation and linker ...

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to ...

South Korea's leading contract development and manufacturing organization Samsung Biologics said Monday it will participate ...